Rafi Ahmed Selected Research

Rafi Ahmed Research Topics

Disease

104	Infections 11/2022 - 01/2002
60	Virus Diseases (Viral Diseases) 11/2022 - 04/2002
39	Neoplasms (Cancer) 11/2022 - 11/2004
31	Persistent Infection 01/2019 - 10/2002
27	Human Influenza (Influenza) 02/2022 - 05/2005
12	COVID-19 11/2022 - 01/2020
8	Viremia 09/2021 - 11/2002
7	Dengue (Dengue Fever) 11/2021 - 07/2014
7	Yellow Fever 01/2021 - 05/2008
6	Communicable Diseases (Infectious Diseases) 11/2018 - 03/2004
6	Smallpox (Variola) 03/2011 - 11/2003
5	Reinfection 11/2022 - 10/2004
5	Pneumonia (Pneumonitis) 12/2021 - 01/2018
5	Vaccinia 09/2021 - 05/2005
5	Ebola Hemorrhagic Fever 11/2018 - 08/2003
4	Lung Neoplasms (Lung Cancer) 11/2022 - 01/2017
4	Inflammation (Inflammations) 12/2021 - 01/2012
4	Herpes Zoster 01/2019 - 05/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2017
3	Disease Progression 01/2022 - 03/2009
3	HIV Infections (HIV Infection) 01/2018 - 06/2007
3	Malaria 01/2017 - 02/2011
2	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2015
2	Shock 11/2021 - 05/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 11/2018 - 10/2015
2	Hepatitis B 01/2018 - 02/2008
2	Influenza in Birds (Avian Flu) 01/2018 - 09/2014
2	Zika Virus Infection 12/2017 - 12/2016
2	Coinfection 01/2016 - 07/2014
2	Cytokine Release Syndrome 01/2015 - 10/2010
2	Acquired Immunodeficiency Syndrome (AIDS) 03/2014 - 05/2013
2	Inhalation anthrax 11/2012 - 10/2004
2	Bacterial Infections (Bacterial Infection) 08/2010 - 08/2002
2	Anthrax 08/2005 - 10/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022

Drug/Important Bio-Agent (IBA)

60	VaccinesIBA 10/2022 - 10/2002
48	AntigensIBA 01/2022 - 04/2002
42	AntibodiesIBA 11/2022 - 01/2003
25	EpitopesIBA 01/2021 - 04/2002
18	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2002
15	Neutralizing AntibodiesIBA 11/2022 - 01/2011
15	CytokinesIBA 11/2021 - 01/2002
15	Immunoglobulin G (IgG)IBA 01/2021 - 01/2003
11	Proteins (Proteins, Gene)FDA Link 02/2021 - 02/2003
11	LigandsIBA 03/2019 - 10/2006
10	Monoclonal AntibodiesIBA 01/2022 - 01/2011
6	Granzymes (Granzyme)IBA 09/2021 - 02/2007
6	Glycoproteins (Glycoprotein)IBA 10/2020 - 10/2003
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 04/2008
6	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 01/2011
5	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 06/2007
5	Interleukin-2 (IL2)IBA 01/2019 - 05/2003
5	Broadly Neutralizing AntibodiesIBA 01/2016 - 01/2011
5	Immunoglobulins (Immunoglobulin)IBA 01/2015 - 10/2004
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2007
4	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2020 - 09/2014
4	B7-H1 AntigenIBA 01/2018 - 09/2007
3	mRNA VaccinesIBA 11/2022 - 01/2022
3	Pharmaceutical PreparationsIBA 12/2021 - 11/2007
3	NucleoproteinsIBA 01/2021 - 10/2003
3	Immunoglobulin M (IgM)IBA 01/2021 - 10/2007
3	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 01/2017
3	Immune Checkpoint InhibitorsIBA 01/2019 - 03/2014
3	A-Form DNA (A-DNA)IBA 01/2019 - 06/2007
3	PerforinIBA 01/2018 - 07/2003
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2018 - 04/2003
3	Sirolimus (Rapamycin)FDA Link 01/2017 - 07/2009
3	Biological ProductsIBA 07/2014 - 08/2008
3	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 11/2012 - 05/2007
3	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 06/2011 - 08/2008
2	Rituximab (Mabthera)FDA Link 11/2022 - 02/2015
2	Immunodominant EpitopesIBA 02/2022 - 05/2007
2	Oxygen (Dioxygen)IBA 12/2021 - 12/2020
2	2019-nCoV Vaccine mRNA-1273IBA 02/2021 - 02/2021
2	Attenuated VaccinesIBA 01/2021 - 04/2008
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 09/2019 - 10/2010
2	Interleukin-15 (Interleukin 15)IBA 01/2019 - 11/2004
2	Herpes Zoster VaccineIBA 01/2019 - 01/2018
2	EnzymesIBA 01/2019 - 10/2008
2	Interleukin-7 (Interleukin 7)IBA 01/2019 - 11/2004
2	Programmed Cell Death 1 ReceptorIBA 01/2018 - 10/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 01/2003
2	Peptides (Polypeptides)IBA 01/2018 - 05/2005
2	Blocking AntibodiesIBA 01/2018 - 01/2015
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018 - 09/2015
2	Malaria VaccinesIBA 01/2017 - 12/2013
2	Viral ProteinsIBA 04/2015 - 03/2013
2	Viral AntigensIBA 02/2015 - 01/2004
2	MucinsIBA 01/2015 - 08/2010
2	Interleukin-10 (Interleukin 10)IBA 03/2014 - 08/2010
2	Indicators and Reagents (Reagents)IBA 12/2009 - 08/2002
1	COVID-19 VaccinesIBA 11/2022

Therapy/Procedure

22	Therapeutics 01/2022 - 03/2009
18	Immunotherapy 01/2022 - 10/2007
6	Radiotherapy 12/2021 - 10/2015
2	Transplantation 11/2019 - 08/2010